by Faye Sakellaridis
The Medicines & Healthcare products Regulatory Agency in the UK has acknowledged the medicinal value of cannabidiol (CBD), the non psychoactive component of cannabis, and has classified it as a medicine following a number of “overt medicinal claims” made by manufacturing companies.
Gerard Heddel, director of inspection and enforcement at the agency, told the online British news website Sky News that they “noted that people were making some quite stark claims about serious diseases that could be treated with CBD.” After reviewing the evidence, they concluded “it was clear that people are using this product with the understandable belief that it will actually help.”
Sky News reports one UK citizen whose five year old daughter was able to drastically mitigate the number of seizures she had with the use of CBD. Scientific research has already shown CBD to be therapeutic for a variety of conditions, including mental illness, cancer, diabetes, epilepsy, and more.
While Sky News cites concerns that the move could send mixed messages about cannabis at large, UK medical professionals stress that this ruling only applies to CBD in isolation.
While cannabis is not recognized in UK as having any therapeutic value, this move does open up the debate for medical marijuana there.